publication date: Feb. 11, 2011

• ODAC Calls for Tougher Standards for Accelerated Approval in Oncology • Sponsors Withdraw Indications for Iressa, Celebrex
• Doroshow: NCI Leaves it up to Groups to Make their own Merger Deals • White House yet to Name NCAB, Cancer Panel Members • NCI Largely Unaffected by NIH Translational Research Center
Download PDF

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.